Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 631063, 9 pages
http://dx.doi.org/10.1155/2013/631063
Research Article

Modulation of LPS-Induced CD4+ T-Cell Activation and Apoptosis by Antioxidants in Untreated Asymptomatic HIV Infected Participants: An In Vitro Study

1Haematology Division, Department of Pathology, Faculty of Medicine and Health Science, Stellenbosch University, P.O. Box 19063, Tygerberg, Cape Town 7505, South Africa
2Oxidative Stress Research Centre, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, P.O. Box 1906, Bellville 7535, South Africa

Received 13 August 2013; Revised 8 October 2013; Accepted 14 October 2013

Academic Editor: Oscar Bottasso

Copyright © 2013 S. Mburu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Brenchley, D. A. Price, T. W. Schacker et al., “Microbial translocation is a cause of systemic immune activation in chronic HIV infection,” Nature Medicine, vol. 12, no. 12, pp. 1365–1371, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. D. C. Douek, M. Roederer, and R. A. Koup, “Emerging concepts in the immunopathogenesis of AIDS,” Annual Review of Medicine, vol. 60, pp. 471–484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. D. Hazenberg, S. A. Otto, B. H. B. Van Benthem et al., “Persistent immune activation in HIV-1 infection is associated with progression to AIDS,” AIDS, vol. 17, no. 13, pp. 1881–1888, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. J. V. Giorgi, Z. Liu, L. E. Hultin, W. G. Cumberland, K. Hennessey, and R. Detels, “Elevated levels of CD38+CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up,” Journal of Acquired Immune Deficiency Syndromes, vol. 6, no. 8, pp. 904–912, 1993. View at Google Scholar · View at Scopus
  5. Z. Liu, W. G. Cumberland, L. E. Hultin, A. H. Kaplan, R. Detels, and J. V. Giorgi, “CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 18, no. 4, pp. 332–340, 1998. View at Google Scholar · View at Scopus
  6. J. L. Fahey, J. M. G. Taylor, B. Manna et al., “Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements,” AIDS, vol. 12, no. 13, pp. 1581–1590, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Meier, E. Dayer, E. Blanc, and J.-P. Wauters, “Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease,” Journal of the American Society of Nephrology, vol. 13, no. 1, pp. 204–212, 2002. View at Google Scholar · View at Scopus
  8. A. Savarino, F. Bottarel, F. Malavasi, and U. Dianzani, “Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions?” AIDS, vol. 14, no. 9, pp. 1079–1089, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Benito, M. López, S. Lozano et al., “Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy,” Journal of Acquired Immune Deficiency Syndromes, vol. 38, no. 4, pp. 373–381, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Brenchley, T. W. Schacker, L. E. Ruff et al., “CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract,” The Journal of Experimental Medicine, vol. 200, no. 6, pp. 749–759, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Cassol, S. Malfeld, P. Mahasha et al., “Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy,” Journal of Infectious Diseases, vol. 202, no. 5, pp. 723–733, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Xu, M. Komai-Koma, and F. Y. Liew, “Expression and function of Toll-like receptor on T cells,” Cellular Immunology, vol. 233, no. 2, pp. 85–89, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Kabelitz, “Expression and function of Toll-like receptors in T lymphocytes,” Current Opinion in Immunology, vol. 19, no. 1, pp. 39–45, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Bellezzo, K. A. Leingang, G. A. Bulla, R. S. Britton, B. R. Bacon, and E. S. Fox, “Modulation of lipopolysaccharide-mediated activation in rat Kupffer cells by antioxidants,” Journal of Laboratory and Clinical Medicine, vol. 131, no. 1, pp. 36–44, 1998. View at Google Scholar · View at Scopus
  15. C. Tincati, G. M. Bellistrì, G. Ancona, E. Merlini, A. D'Arminio Monforte, and G. Marchetti, “Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients,” Clinical and Developmental Immunology, vol. 2012, Article ID 935425, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Martín-Romero, J. Santos-Alvarez, R. Goberna, and V. Sánchez-Margalet, “Human leptin enhances activation and proliferation of human circulating T lymphocytes,” Cellular Immunology, vol. 199, no. 1, pp. 15–24, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Åkerlund, C. Jarstrand, B. Lindeke, A. Sönnerborg, A.-C. Åkerblad, and O. Rasool, “Effect of N-acetylcysteine(NAC) treatment on HIV-1 infection: a double blind placebo controlled trial,” European Journal of Clinical Pharmacology, vol. 50, no. 6, pp. 457–461, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. P. A. Sandstrom, M. D. Mannie, and T. M. Butke, “Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis,” Journal of Leukocyte Biology, vol. 55, no. 2, pp. 221–226, 1994. View at Google Scholar · View at Scopus
  19. W. Malorni, R. Rivabene, M. T. Santini, and G. Donelli, “N-acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells,” FEBS Letters, vol. 327, no. 1, pp. 75–78, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. R. L. Roberts, V. R. Aroda, and B. J. Ank, “N-acetylcysteine enhances antibody-dependent cellular cytotoxicity in neutrophils and mononuclear cells from healthy adults and human immunodeficiency virus-infected patients,” Journal of Infectious Diseases, vol. 172, no. 6, pp. 1492–1502, 1995. View at Google Scholar · View at Scopus
  21. S. Oddera, M. Silvestri, O. Sacco, C. Eftimiadi, and G. A. Rossi, “N-Acetylcysteine enhances in vitro the intracellular killing of Staphylococcus aureus by human alveolar macrophages and blood polymorphonuclear leukocytes and partially protects phagocytes from self-killing,” Journal of Laboratory and Clinical Medicine, vol. 124, no. 2, pp. 293–301, 1994. View at Google Scholar · View at Scopus
  22. R. F. Cathcart III, “Vitamin C in the treatment of Acquired Immune Deficiency Syndrome (AIDS),” Medical Hypotheses, vol. 14, no. 4, pp. 423–433, 1984. View at Google Scholar · View at Scopus
  23. J. P. Allard, E. Aghdassi, J. Chau, I. Salit, and S. Walmsley, “Oxidative stress and plasma antioxidant micronutrients in with HIV infection,” American Journal of Clinical Nutrition, vol. 67, no. 1, pp. 143–147, 1998. View at Google Scholar · View at Scopus
  24. W. W. Fawzi, G. I. Msamanga, D. Hunter et al., “Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality,” AIDS, vol. 16, no. 14, pp. 1935–1944, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. J. D. Kaiser, A. M. Campa, J. P. Ondercin, G. S. Leoung, R. F. Pless, and M. K. Baum, “Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial,” Journal of Acquired Immune Deficiency Syndromes, vol. 42, no. 5, pp. 523–528, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. G. Bowie and L. A. J. O'Neill, “Vitamin C inhibits NF-κB activation by TNF via the activation of p38 mitogen-activated protein kinase,” Journal of Immunology, vol. 165, no. 12, pp. 7180–7188, 2000. View at Google Scholar · View at Scopus
  27. I. Perez-Cruz, J. M. Carcamo, and D. W. Golde, “Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells,” Blood, vol. 102, no. 1, pp. 336–343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Saitoh, R. Ouchida, A. Kayasuga, and N. Miwa, “Anti-apoptotic defense of bcl-2 gene against hydroperoxide-induced cytotoxicity together with suppressed lipid peroxidation, enhanced ascorbate uptake, and upregulated Bcl-2 protein,” Journal of Cellular Biochemistry, vol. 89, no. 2, pp. 321–334, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Pavlovic, S. Cekic, V. Bojanic, N. Stojiljijkovic, and G. Rankovic, “Ascorbic acid modulates spontaneous thymocyte apoptosis,” Acta Medica Medianae, pp. 21–23, 2005. View at Google Scholar
  30. A. Carr and B. Frei, “Does vitamin C act as a pro-oxidant under physiological conditions?” FASEB Journal, vol. 13, no. 9, pp. 1007–1024, 1999. View at Google Scholar · View at Scopus
  31. S. H. Lee, Y. C. Yoon, Y. Y. Jang, J. H. Song, E. S. Han, and C. S. Lee, “Effect of iron and ascorbate on cyclosporine-induced oxidative damage of kidney mitochondria and microsomes,” Pharmacological Research, vol. 43, no. 2, pp. 161–171, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Bergman, H. Salman, M. Djaldetti, L. Fish, I. Punsky, and H. Bessler, “In vitro immune response of human peripheral blood cells to vitamins C and E,” Journal of Nutritional Biochemistry, vol. 15, no. 1, pp. 45–50, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Halliwell, “Vitamin C: antioxidant or pro-oxidant in vivo?” Free Radical Research, vol. 25, no. 5, pp. 439–454, 1996. View at Google Scholar · View at Scopus
  34. K. A. Naidu, “Vitamin C in human health and disease is still a mystery? An overview,” Nutrition Journal, vol. 2, article 1, 2003. View at Publisher · View at Google Scholar · View at Scopus